Quintin J. Lai's most recent trade in West Pharmaceutical Services, Inc. was a trade of 375 Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 375 | 4,358 (0%) | 0% | 0 | Common Stock | |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Sale of securities on an exchange or to another person at price $ 394.62 per share. | 11 Aug 2023 | 10,725 | 28,682 (0%) | 0% | 394.6 | 4,232,326 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 8,772 | 0 | - | - | Stock Option (Right to Buy) | |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.64 per share. | 11 Aug 2023 | 8,772 | 27,078 (0%) | 0% | 89.6 | 786,322 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Sale of securities on an exchange or to another person at price $ 395.54 per share. | 11 Aug 2023 | 8,635 | 20,047 (0%) | 0% | 395.5 | 3,415,510 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 7,140 | 0 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.51 per share. | 11 Aug 2023 | 7,140 | 34,218 (0%) | 0% | 102.5 | 731,921 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 3,348 | 1,116 | - | - | Stock Options (Right to Buy) | |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.22 per share. | 11 Aug 2023 | 3,348 | 37,566 (0%) | 0% | 173.2 | 579,941 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Sale of securities on an exchange or to another person at price $ 396.12 per share. | 11 Aug 2023 | 1,741 | 18,306 (0%) | 0% | 396.1 | 689,650 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 1,388 | 1,388 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 274.29 per share. | 11 Aug 2023 | 1,388 | 38,954 (0%) | 0% | 274.3 | 380,715 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 453 | 1,359 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Quintin J. Lai | VP Strat & Investor Relations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 369.13 per share. | 11 Aug 2023 | 453 | 39,407 (0%) | 0% | 369.1 | 167,216 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 1,724 | 1,724 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Grant, award, or other acquisition of securities at price $ 306.68 per share. | 21 Feb 2023 | 1,134 | 18,306 (0%) | 0% | 306.7 | 347,775 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.47 per share. | 14 Mar 2022 | 5,576 | 13,387 (0%) | 0% | 83.5 | 465,429 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 5,576 | 29,064 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 374.45 per share. | 14 Mar 2022 | 2,940 | 5,571 (0%) | 0% | 374.4 | 1,100,881 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.27 per share. | 14 Mar 2022 | 2,440 | 7,811 (0%) | 0% | 94.3 | 230,019 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 2,440 | 34,640 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 367.12 per share. | 14 Mar 2022 | 1,271 | 12,116 (0%) | 0% | 367.1 | 466,604 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 369.86 per share. | 14 Mar 2022 | 1,254 | 10,457 (0%) | 0% | 369.9 | 463,801 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 372.92 per share. | 14 Mar 2022 | 900 | 8,511 (0%) | 0% | 372.9 | 335,632 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 371.89 per share. | 14 Mar 2022 | 600 | 9,411 (0%) | 0% | 371.9 | 223,132 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 370.94 per share. | 14 Mar 2022 | 446 | 10,011 (0%) | 0% | 370.9 | 165,441 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 367.94 per share. | 14 Mar 2022 | 405 | 11,711 (0%) | 0% | 367.9 | 149,017 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 374.92 per share. | 14 Mar 2022 | 200 | 5,371 (0%) | 0% | 374.9 | 74,984 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Grant, award, or other acquisition of securities at price $ 369.13 per share. | 22 Feb 2022 | 3,138 | 5,371 (0%) | 0% | 369.1 | 1,158,330 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 1,812 | 1,812 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.64 per share. | 10 Sep 2021 | 8,672 | 10,905 (0%) | 0% | 59.6 | 517,198 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2021 | 8,672 | 0 | - | - | Stock Option (Right to Buy) | |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 460.18 per share. | 10 Sep 2021 | 5,072 | 6,833 (0%) | 0% | 460.2 | 2,334,012 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 460.80 per share. | 10 Sep 2021 | 3,100 | 3,733 (0%) | 0% | 460.8 | 1,428,494 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Sale of securities on an exchange or to another person at price $ 462.63 per share. | 10 Sep 2021 | 1,500 | 2,233 (0%) | 0% | 462.6 | 693,946 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.97 per share. | 10 Sep 2021 | 1,000 | 11,905 (0%) | 0% | 73.0 | 72,970 | Common Stock |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2021 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 2,776 | 2,776 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Quintin J. Lai | VP Corp Development & Strategy | Grant, award, or other acquisition of securities at price $ 272.65 per share. | 22 Feb 2021 | 2,936 | 2,936 (0%) | 0% | 272.6 | 800,500 | Common Stock |